NOD1 activation reportedly fosters an immunosuppressive tumour microenvironment to promote CRC development in both colitis‐associated carcinogenesis and spontaneous carcinogenesis (Maisonneuve et al., 2021). This evidence concerns the gene NOD1 and colorectal carcinoma.